Voss Capital, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

Filing Manager
Voss Capital, LP
Reporting Manager
Voss Capital, LP
Security
Rein Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RNTX
Shares outstanding
26,288,053 shares
Disclosed Ownership
4,468,969 shares
Ownership
17%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 16:15:26 UTC
Date of event
31 Dec 2025
Previous filing
26 Sep 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Voss Value Master Fund, LP 3.5% 926,441 926,441 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Value-Oriented Special Situations Fund, LP 1.9% 500,000 500,000 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Advisors GP, LLC 5.4% 1,426,441 1,426,441 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Voss Capital, LP 17% 4,468,969 3,776,484 692,485 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Cocke Travis W. 17% 4,468,969 3,776,484 692,485 /s/ Travis W. Cocke Travis W. Cocke